| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,235 |
17,632 |
$2.41M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,523 |
12,174 |
$2.29M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,030 |
2,690 |
$691K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,170 |
1,909 |
$528K |
| 80050 |
General health panel |
9,764 |
8,695 |
$393K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
520 |
459 |
$374K |
| G0378 |
Hospital observation service, per hour |
1,178 |
648 |
$350K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,870 |
9,114 |
$229K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,104 |
1,035 |
$210K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,130 |
3,668 |
$195K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
514 |
451 |
$172K |
| 76830 |
Ultrasound, transvaginal |
809 |
766 |
$157K |
| 71045 |
Radiologic examination, chest; single view |
3,312 |
2,935 |
$135K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
455 |
415 |
$119K |
| G0379 |
Direct admission of patient for hospital observation care |
305 |
258 |
$115K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,356 |
1,138 |
$111K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,950 |
4,367 |
$95K |
| 70450 |
Computed tomography, head or brain; without contrast material |
762 |
691 |
$93K |
| 36415 |
Collection of venous blood by venipuncture |
30,886 |
27,191 |
$72K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,638 |
1,460 |
$68K |
| 80081 |
|
835 |
782 |
$59K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,900 |
378 |
$58K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
567 |
535 |
$50K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,422 |
1,321 |
$50K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
986 |
939 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,478 |
8,081 |
$43K |
| 97597 |
|
1,372 |
544 |
$40K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
510 |
446 |
$37K |
| 80053 |
Comprehensive metabolic panel |
6,247 |
5,432 |
$36K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
603 |
548 |
$32K |
| 80061 |
Lipid panel |
2,728 |
2,565 |
$29K |
| 81001 |
|
13,252 |
11,417 |
$29K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,368 |
1,246 |
$28K |
| 87400 |
|
1,222 |
1,128 |
$28K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
868 |
818 |
$27K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
868 |
818 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
355 |
334 |
$25K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,398 |
3,075 |
$25K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
268 |
245 |
$24K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
658 |
510 |
$20K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
242 |
186 |
$20K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,103 |
228 |
$20K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
795 |
658 |
$19K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
60 |
54 |
$18K |
| 94761 |
|
1,059 |
861 |
$16K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
28 |
27 |
$15K |
| 84484 |
|
2,320 |
2,035 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
338 |
315 |
$14K |
| 0240U |
|
138 |
126 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
459 |
401 |
$13K |
| 82553 |
|
2,284 |
1,970 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
484 |
291 |
$12K |
| 72114 |
|
105 |
99 |
$11K |
| 83021 |
|
625 |
573 |
$10K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
54 |
32 |
$10K |
| 81025 |
|
1,478 |
1,306 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,337 |
1,188 |
$9K |
| 82550 |
|
2,501 |
2,199 |
$9K |
| 83690 |
|
1,881 |
1,677 |
$8K |
| 84481 |
|
712 |
661 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
592 |
498 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
282 |
255 |
$8K |
| 83880 |
|
460 |
417 |
$8K |
| 87430 |
|
590 |
557 |
$8K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
159 |
129 |
$8K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
217 |
65 |
$7K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
221 |
215 |
$7K |
| 86803 |
|
561 |
530 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,640 |
1,471 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
896 |
832 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
257 |
242 |
$6K |
| 84439 |
|
713 |
647 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
836 |
758 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
323 |
264 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
135 |
134 |
$5K |
| 94760 |
|
1,174 |
1,025 |
$5K |
| 43235 |
|
14 |
12 |
$4K |
| 0002A |
|
138 |
114 |
$4K |
| 86762 |
|
280 |
243 |
$4K |
| 82950 |
|
743 |
690 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
890 |
770 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
78 |
76 |
$3K |
| 87660 |
|
177 |
167 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
28 |
27 |
$3K |
| 73562 |
|
29 |
27 |
$3K |
| 87340 |
|
337 |
290 |
$3K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
313 |
303 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
45 |
45 |
$3K |
| 87480 |
|
178 |
168 |
$3K |
| 87510 |
|
178 |
168 |
$3K |
| 86592 |
|
733 |
675 |
$3K |
| J0595 |
Injection, butorphanol tartrate, 1 mg |
530 |
463 |
$3K |
| 85660 |
|
512 |
474 |
$3K |
| 83735 |
|
536 |
471 |
$2K |
| 84702 |
|
170 |
151 |
$2K |
| 85730 |
|
771 |
674 |
$2K |
| 73130 |
|
13 |
12 |
$2K |
| 0001A |
|
88 |
73 |
$2K |
| 73564 |
|
13 |
13 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
4,921 |
4,096 |
$2K |
| 86850 |
|
718 |
618 |
$2K |
| 85610 |
|
862 |
754 |
$2K |
| 82670 |
|
57 |
57 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
16 |
16 |
$2K |
| 85014 |
|
782 |
721 |
$2K |
| 85018 |
|
779 |
720 |
$2K |
| 83655 |
|
121 |
121 |
$2K |
| 36600 |
|
141 |
119 |
$1K |
| 87186 |
|
169 |
155 |
$1K |
| 82043 |
|
304 |
293 |
$1K |
| 86704 |
|
100 |
99 |
$1K |
| 86900 |
|
739 |
640 |
$1K |
| 86706 |
|
100 |
99 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
193 |
182 |
$1K |
| 43450 |
|
746 |
529 |
$1K |
| 86901 |
|
712 |
617 |
$1K |
| 84402 |
|
45 |
45 |
$1K |
| 84146 |
|
55 |
55 |
$1K |
| 84403 |
|
44 |
44 |
$1K |
| 82607 |
|
68 |
67 |
$949.50 |
| 74018 |
|
16 |
13 |
$940.60 |
| 88312 |
|
680 |
628 |
$937.94 |
| 82746 |
|
56 |
55 |
$749.16 |
| 87040 |
|
103 |
73 |
$746.74 |
| 86708 |
|
56 |
55 |
$726.94 |
| 82728 |
|
46 |
38 |
$494.59 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
71 |
62 |
$471.22 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13 |
13 |
$468.97 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
14 |
14 |
$423.22 |
| 87521 |
Neg quan hep c or qual rna |
13 |
12 |
$421.08 |
| 87807 |
|
30 |
28 |
$408.80 |
| 87070 |
|
42 |
41 |
$405.92 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
44 |
38 |
$401.62 |
| 86705 |
|
29 |
28 |
$373.17 |
| 82803 |
|
117 |
107 |
$345.98 |
| 82677 |
|
15 |
13 |
$338.52 |
| 82105 |
|
29 |
25 |
$335.40 |
| 82150 |
|
71 |
69 |
$331.18 |
| 85027 |
|
91 |
86 |
$289.61 |
| 80320 |
|
26 |
25 |
$288.00 |
| 80179 |
|
24 |
17 |
$279.60 |
| 80143 |
|
24 |
17 |
$279.60 |
| 83001 |
|
15 |
15 |
$278.70 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
60 |
53 |
$251.01 |
| 86140 |
|
70 |
69 |
$248.64 |
| 83550 |
|
29 |
26 |
$238.46 |
| 85379 |
|
41 |
39 |
$234.14 |
| 84134 |
|
40 |
39 |
$220.11 |
| 86336 |
|
15 |
13 |
$218.26 |
| 83540 |
|
29 |
26 |
$166.90 |
| 86709 |
|
16 |
15 |
$157.64 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
60 |
52 |
$151.36 |
| 83605 |
|
31 |
28 |
$145.09 |
| 87350 |
|
13 |
12 |
$138.36 |
| 82570 |
|
34 |
26 |
$126.58 |
| 85651 |
|
41 |
40 |
$123.83 |
| 84156 |
|
34 |
26 |
$89.70 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,520 |
1,234 |
$87.31 |
| J2060 |
Injection, lorazepam, 2 mg |
35 |
29 |
$69.28 |
| 85007 |
|
14 |
13 |
$34.10 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
27 |
27 |
$3.16 |
| 91300 |
|
192 |
150 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
886 |
85 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
44 |
33 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
516 |
417 |
$0.00 |
| A4270 |
Disposable endoscope sheath, each |
25 |
25 |
$0.00 |